T. Cerny

1.1k total citations
16 papers, 692 citations indexed

About

T. Cerny is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, T. Cerny has authored 16 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in T. Cerny's work include Chemotherapy-induced organ toxicity mitigation (6 papers), Neuroendocrine Tumor Research Advances (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). T. Cerny is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (6 papers), Neuroendocrine Tumor Research Advances (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). T. Cerny collaborates with scholars based in Switzerland, United Kingdom and Denmark. T. Cerny's co-authors include N. Thatcher, H. Anderson, V Blair, A Küpfer, C. Aeschlimann, P M Wilkinson, J. Margison, Michael Lind, Roger von Moos and K. Kaufmann and has published in prestigious journals such as Cancer, British Journal of Cancer and Annals of Oncology.

In The Last Decade

T. Cerny

16 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Cerny Switzerland	11	310	226	167	150	131	16	692
Beste M. Atasoy Türkiye	17	245 0.8×	88 0.4×	52 0.3×	242 1.6×	173 1.3×	60	945
John S. Moody United States	14	298 1.0×	93 0.4×	65 0.4×	300 2.0×	110 0.8×	22	894
Finn Ole Larsen Denmark	17	550 1.8×	94 0.4×	46 0.3×	237 1.6×	88 0.7×	49	877
Carlo Mulas Italy	11	246 0.8×	26 0.1×	98 0.6×	74 0.5×	221 1.7×	19	871
Xuesong Guan United States	11	279 0.9×	84 0.4×	177 1.1×	87 0.6×	612 4.7×	21	1.7k
Elissa Furutani United States	9	99 0.3×	87 0.4×	49 0.3×	64 0.4×	105 0.8×	18	539
J C Michalak United States	9	231 0.7×	91 0.4×	23 0.1×	104 0.7×	44 0.3×	12	554
Diana Flores‐Estrada Mexico	16	477 1.5×	47 0.2×	124 0.7×	284 1.9×	143 1.1×	41	1.0k
Alida J. Evans United States	11	133 0.4×	132 0.6×	71 0.4×	85 0.6×	538 4.1×	13	1.1k
Francesco Trimarchi Italy	16	93 0.3×	72 0.3×	105 0.6×	45 0.3×	136 1.0×	27	789

Countries citing papers authored by T. Cerny

Since Specialization

Citations

This map shows the geographic impact of T. Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Cerny more than expected).

Fields of papers citing papers by T. Cerny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Cerny. The network helps show where T. Cerny may publish in the future.

Co-authorship network of co-authors of T. Cerny

This figure shows the co-authorship network connecting the top 25 collaborators of T. Cerny. A scholar is included among the top collaborators of T. Cerny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Cerny. T. Cerny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Strasser, Florian, Thomas A. Lutz, Micha T. Maeder, et al.. (2008). Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. British Journal of Cancer. 98(2). 300–308. 129 indexed citations

Leyvraz, Serge, Richard Herrmann, L Guillou, et al.. (2006). Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies. British Journal of Cancer. 95(10). 1342–1347. 8 indexed citations

Ghielmini, Michele, Kurt Bürki, Gabriella Pichert, et al.. (2000). The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK).. PubMed. 11 Suppl 1. 123–6. 63 indexed citations

Schroth, G, et al.. (1999). Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapy. Journal of Clinical Neuroscience. 6(3). 247–249. 9 indexed citations

Leyvraz, Serge, M. Bacchi, T. Cerny, et al.. (1998). Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Annals of Oncology. 9(8). 877–884. 39 indexed citations

Aeschlimann, C., A Küpfer, H Schefer, & T. Cerny. (1998). Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy.. PubMed. 26(9). 883–90. 29 indexed citations

Judson, Ian, T. Cerny, Ron Epelbaum, et al.. (1997). Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation. Annals of Oncology. 8(6). 604–606. 46 indexed citations

Aeschlimann, C., T. Cerny, & A Küpfer. (1996). Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.. Drug Metabolism and Disposition. 24(12). 1336–1339. 57 indexed citations

Borner, M., et al.. (1993). Bioavailability and feasibility of subcutaneous 5-fluorouracil. British Journal of Cancer. 68(3). 537–539. 5 indexed citations

10.

Cerny, T., et al.. (1991). Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility. Journal of Cancer Research and Clinical Oncology. 117(S4). S129–S134. 5 indexed citations

11.

Rohr, A. von, T. Cerny, R Joss, & Kurt Brunner. (1991). [Syndrome of inappropriate ADH secretion (SIADH) in small-cell bronchus carcinoma].. PubMed. 121(36). 1271–82. 3 indexed citations

12.

Margison, J., et al.. (1990). The effect of age on the pharmacokinetics of ifosfamide.. British Journal of Clinical Pharmacology. 30(1). 140–143. 21 indexed citations

13.

Lind, Michael, J. Margison, T. Cerny, N. Thatcher, & P M Wilkinson. (1989). Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinoma. Lung Cancer. 5(2-3). 112–112. 59 indexed citations

14.

Thatcher, Nick, et al.. (1987). Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer. Cancer. 60(10). 2382–2387. 28 indexed citations

15.

Cerny, T., et al.. (1987). Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patients. International Journal of Cancer. 39(2). 146–149. 164 indexed citations

16.

Wilkinson, P M, et al.. (1986). A simple quantitative HPLC assay for ifosfamide in biological fluids. Biomedical Chromatography. 1(3). 101–103. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact